TechWald Next S.p.A.

TechWald Next S.p.A. is an operational holding company dedicated to supporting high-growth potential early-stage companies committed to developing healthcare innovations. The company focuses on the MedTech industry, encompassing medical devices, equipment, digital devices, and services that provide value to patients, doctors, and healthcare systems. TechWald Next S.p.A. aims to deliver ethical profits to shareholders by investing in technologies that enhance healthcare delivery and patient outcomes.

The company's investment strategy emphasizes sectors such as healthcare, MedTech, medical devices, digital health, and life sciences. TechWald Next S.p.A. engages in various stages of investment, including seed, early stage, Series A, Series B, growth, and late stage, with a minimum investment size of €3 million. This approach allows the firm to support companies at different development phases, from initial concept to market expansion.

TechWald Next S.p.A. has a track record of investing in innovative healthcare companies. For instance, in October 2024, the company co-led a €17.9 million Series B funding round for Lymphatica Medtech SA, a clinical-stage company specializing in treatments for lymphedema. This investment underscores TechWald Next S.p.A.'s commitment to advancing medical technologies that address unmet patient needs and improve healthcare outcomes.